# NativeMed Review: Longevity Care Scope and Costs | HealthspanNerds Canonical: https://healthspannerds.com/reviews/nativemed/ Published: 2026-10-29 Updated: 2026-10-29 Compare NativeMed NAD+, sermorelin and weight-care prices, clinical responsibilities and refund scope without treating the menu as a complete prevention plan. [Reviews](https://healthspannerds.com/providers/)/NativeMed Treatment-specific metabolic and longevity care # NativeMed review NativeMed combines a menu of metabolic and longevity services with separate treatment prices. It suits a defined clinical task; the menu does not establish comprehensive preventive care or a longer-life benefit. EG[Ellis Grant](https://healthspannerds.com/authors/ellis-grant/)Consumer Editor · Updated October 2026 ## A useful next step? Consider the purpose, the care relationship and the full commitment. Visit NativeMed↗Official provider website. No affiliate relationship is currently listed. ## A reason to consider it Readers comparing a specific prescribing relationship, its follow-up responsibilities and full purchase cost. - The catalog separates weight-care, NAD+ and sermorelin services. - Product selectors distinguish some monthly and longer-plan prices. - A pharmacy policy names clinical, dispensing and order-support responsibilities. ## What deserves scrutiny People expecting a single prevention membership, a complete laboratory program or proof of improved healthspan from a treatment menu. - There is no single complete prevention-plan price. - Longevity selectors do not state complete upfront totals. - The weight-loss contract and refund exception should not be assigned to every product. ## A treatment menu needs a specific clinical task NativeMed offers weight-care, NAD+ and sermorelin pathways under a broader longevity message. I would compare one of those services for a defined need, not buy the menu as a complete prevention program. Provider oversight and metabolic language do not establish which assessments, laboratory tests or follow-up appointments are included for every buyer. The longevity page itself says involvement depends on the treatment plan and personal needs. [\[1\]](https://healthspannerds.com/reviews/nativemed/#reference-1) That makes the selected relationship more important than the breadth of the catalog. Someone managing cardiovascular risk, strength or persistent symptoms needs an appropriate clinical plan and coordination with existing care. Another prescription does not automatically answer those tasks. NativeMed’s platform terms say its telehealth interactions do not replace the relationship with a primary-care clinician. [\[2\]](https://healthspannerds.com/reviews/nativemed/#reference-2) Keep a meaningful functional outcome visible with [our physical-function evidence guide](https://healthspannerds.com/research/grip-strength-physical-function/). Another treatment-specific menu to compare is [our ReadyRx care-scope review](https://healthspannerds.com/reviews/readyrx/). ## Each product has its own financial commitment The NAD+ monthly selection shows $189, while its three-month selection shows $160 per month. Sermorelin shows $159 monthly or $149 per month for three months. Neither longevity selector establishes a complete upfront total for the longer option. I would obtain the actual charge, supplied prescription and renewal before adding either service to a continuing budget. Do not turn an arithmetic estimate into an invoice. [\[3\]](https://healthspannerds.com/reviews/nativemed/#reference-3) [\[4\]](https://healthspannerds.com/reviews/nativemed/#reference-4) Weight-care prices follow different cards. Semaglutide shows $447 upfront for three months, or an introductory $159 month followed by $179 monthly. Tirzepatide shows $549 upfront for three months, or $199 first and $259 thereafter. Those are separate offers, not components of one healthspan membership. A lower equivalent for one treatment cannot establish the total cost of a coordinated care program. [\[5\]](https://healthspannerds.com/reviews/nativemed/#reference-5) [\[6\]](https://healthspannerds.com/reviews/nativemed/#reference-6) Separate treatment prices and unknown expenses in [the full care-cost planner](https://healthspannerds.com/tools/cost-planner/). ## Refund scope and clinical contacts belong in the agreement The refund policy generally describes program payments as nonrefundable. Its twenty-four-hour exception is labeled for weight-loss purchases, requires that medication has not shipped and includes an unquoted administrative cancellation fee. That does not create an NAD+ or sermorelin trial window. Obtain the terms for the chosen service rather than apply a reassuring homepage cancellation statement to every paid order. [\[7\]](https://healthspannerds.com/reviews/nativemed/#reference-7) NativeMed’s pharmacy policy gives a useful separation of responsibilities: treatment concerns go to the provider, dispensing and storage questions to the pharmacy, and order or shipping questions to support. VialsRx is named as a possible partner, with actual fulfillment dependent on prescription, state and availability. The label identifies the dispenser. Neither the partner list nor ongoing-support language establishes immediate physician access or a universal monitoring calendar. [\[8\]](https://healthspannerds.com/reviews/nativemed/#reference-8) Compare another treatment-specific purchase model in [our PeptidesRx care-scope review](https://healthspannerds.com/reviews/peptidesrx/). ## The useful outcome should guide the purchase NAD+ and sermorelin pages discuss cellular energy, recovery and healthy aging. Those claims do not prove that a service extends healthy life or replaces ordinary prevention. The products are compounded preparations, and FDA does not review compounded drugs for safety, effectiveness and quality before marketing or approve them as finished products. Evidence must remain attached to its actual preparation and patient population. [\[3\]](https://healthspannerds.com/reviews/nativemed/#reference-3) [\[4\]](https://healthspannerds.com/reviews/nativemed/#reference-4) [\[9\]](https://healthspannerds.com/reviews/nativemed/#reference-9) NativeMed earns consideration when one clear treatment and a workable care relationship justify the price. If the goal is to understand an existing test result, preserve physical function or obtain regular nutrition support, compare the service that addresses that need directly. A sound next step should change a clinical or practical decision. Paying for a broader-looking menu is not evidence that it will do so. See why the product and patient population matter in [our SELECT cardiovascular evidence guide](https://healthspannerds.com/research/semaglutide-cardiovascular-select/). ## Understanding the cost Separate services: NAD+ monthly $189 or $160/month on a three-month selection; sermorelin monthly $159 or $149/month on three months, with no complete upfront totals shown for those longer selections. Semaglutide three-month plan $447 upfront; tirzepatide $549. Monthly introductions and renewals differ. No combined healthspan fee or included lab program is inferred. [Build your cost estimate](https://healthspannerds.com/tools/cost-planner/) ## Read alongside this review [Grip strength is a useful signal. Function tells a fuller story.](https://healthspannerds.com/research/grip-strength-physical-function/) [Biological-age tests: what a younger number actually establishes](https://healthspannerds.com/research/biological-age-tests/) ## Sources - NativeMed: longevity service scope and follow-up FAQ - NativeMed: platform scope and applicable supplemental service terms - NativeMed: NAD+ monthly and three-month selector states - NativeMed: sermorelin monthly and three-month selector states - NativeMed: semaglutide monthly introduction and prepaid plan - NativeMed: tirzepatide introduction, renewal and prepaid plan - NativeMed: nonrefundable payments and weight-loss-only 24-hour exception - NativeMed: independent clinical and pharmacy roles, possible dispenser and prescription contacts - FDA: compounded medicines and approval status This review evaluates public service information. It does not claim patient enrollment, product testing or measurement of clinical outcomes.